NCT07305441 Impact Assessment of the Jockey Club REACH & Map Program for Hard-to-reach Older Adults
| NCT ID | NCT07305441 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Hard-to-Reach Elderly |
| Study Type | INTERVENTIONAL |
| Enrollment | 5,500 participants |
| Start Date | 2024-02-05 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5,500 participants in total. It began in 2024-02-05 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to evaluate the impact of the Reach-and-Map project on increasing functional capacity to optimize the functional ability of the vulnerable group of "Hard-to-Reach" older adults through increase the compatibility between their intrinsic capacity and environment.
Eligibility Criteria
Inclusion Criteria: * age \> 60 * able to participate in the impact assessment as evidence by a test score of \> 6 on the Abbreviated Mental Test * has the functional ability to engage in the digital intervention * able to communicate with the researcher Exclusion Criteria: \-
Contact & Investigator
Doris Sau Fung YU
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT07305441 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Hard-to-Reach Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07305441 currently recruiting?
Yes, NCT07305441 is actively recruiting participants. Contact the research team at dyu1@hku.hk for enrollment information.
Where is the NCT07305441 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07305441 clinical trial?
NCT07305441 is sponsored by The University of Hong Kong. The principal investigator is Doris Sau Fung YU at The University of Hong Kong. The trial plans to enroll 5,500 participants.